Figure 3.
Serum hepatitis B virus (HBV) DNA and alanine aminotransaminase (ALT) levels in three (A–C) patients with hepatic failure due to HBV reactivation after withdrawal of lamivudine. The period of lamivudine treatment is indicated.
Serum hepatitis B virus (HBV) DNA and alanine aminotransaminase (ALT) levels in three (A–C) patients with hepatic failure due to HBV reactivation after withdrawal of lamivudine. The period of lamivudine treatment is indicated.